Jan 31, 2024
1:40
For every 40 shares held, investors received 1. The price per share adjusted from $0.15 to $0.00.
The split itself did not change the total investment value.
Sigyn Therapeutics, Inc. (SIGY) trades on the Other OTC in the Biotechnology industry.
Sigyn Therapeutics, Inc. company overviewThe latest split shown was on January 31, 2024. It was a 1-for-40 reverse split, so shareholders received 1 share for every 40 they held.
This history records 2 reverse splits between August 10, 2020 and January 31, 2024.